HB Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
HB Wealth Management's EW Position: Q2 2026 in Review
HB Wealth Management reduced its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, selling an estimated $62.7K and leaving 28,155 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #413.
HB Wealth Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- HB Wealth Management held 28,155 shares of Edwards Lifesciences worth $2.55M as of Q2 2026.
- HB Wealth Management sold 748 Edwards Lifesciences shares in Q2 2026, an estimated $62.7K.
- Edwards Lifesciences made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #413 holding.
- HB Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.